Investigation of the potential of clozapine to cause torsade de pointes (Q35034866)

5 August 2017

1 reference

title

Investigation of the potential of clozapine to cause torsade de pointes (English)

1 reference

5 August 2017

Barbara Warner

1

1 reference

5 August 2017

Peter Hoffmann

series ordinal

2

1 reference

5 August 2017

publication date

1 January 2002

1 reference

5 August 2017

published in

Toxicological Reviews

1 reference

5 August 2017

volume

21

1 reference

5 August 2017

issue

4

1 reference

5 August 2017

page(s)

189-203

1 reference

Assessment of QT interval and QT dispersion for prediction of all-cause and cardiovascular mortality in American Indians: The Strong Heart Study

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF03256196

The potential for QT prolongation and pro-arrhythmia by non-anti-arrhythmic drugs: clinical and regulatory implications. Report on a Policy Conference of the European Society of Cardiology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256196

HERG K+ channels: friend and foe.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256196

Effects of newer atypical antipsychotics on autonomic neurocardiac function: a comparison between amisulpride, olanzapine, sertindole, and clozapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256196

Olanzapine plasma concentrations and clinical response: acute phase results of the North American Olanzapine Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256196

Drugs that prolong QT interval as an unwanted effect: assessing their likelihood of inducing hazardous cardiac dysrhythmias

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256196

In vitro electrophysiological detection of iatrogenic arrhythmogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256196

Proarrhythmic effects of antidepressants and neuroleptic drugs on isolated, spontaneously beating guinea-pig Purkinje fibers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256196

The canine Purkinje fiber: an in vitro model system for acquired long QT syndrome and drug-induced arrhythmogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256196

Cardiorespiratory depression and haemolysis due to thioridazine overdose in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256196

Effect of magnesium sulfate on the haloperidol-induced QT prolongation assessed in the canine in vivo model under the monitoring of monophasic action potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256196

The Effect of Haloperidol on Ventricular Fibrillation Threshold in Pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256196

Clozapine and new-onset ECG abnormalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256196

Transient syncope and ECG changes associated with the concurrent administration of clozapine and diazepam

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256196

Reversal of pathologic cardiac parameters after transition from clozapine to olanzapine treatment: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256196

The association between intravenous haloperidol and prolonged QT interval

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256196

Treatment of schizophrenia and delusional disorder in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256196

Thioridazine-induced torsade de pointes. Successful therapy with isoproterenol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256196

A fatality during haloperidol treatment: mechanism of sudden death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256196

Sudden death in patients receiving clozapine treatment: a preliminary investigation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256196

Myocarditis and cardiomyopathy associated with clozapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256196

The assessment of potential for QT interval prolongation with new pharmaceuticals: impact on drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256196

Interactions of dynorphin A-(1-13) and nociceptin with cardiac D2 binding sites: inhibition of ischemia-evoked release of noradrenaline from synaptosomal-mitochondrial fractions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256196

The inhibitory effect of the antipsychotic drug haloperidol on HERG potassium channels expressed in Xenopus oocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256196

Sudden death in psychiatric patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256196

Out-of-hospital cardiac arrest in the 1990's: a population-based study in the Maastricht area on incidence, characteristics and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256196

Antipsychotics and the risk of sudden cardiac death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256196

Thioridazine: Re-evaluating the Risk/Benefit Equation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256196

21 January 2018

Identifiers

DOI

10.1007/BF03256196

1 reference

5 August 2017

1 reference